Company intelligence / Profile preview
Immunovative Therapies
Jerusalem, Jerusalem District, Israelepo.org ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Phase 2
01
Overview
Immunovative Therapies Ltd. develops novel immunotherapy products designed to elicit anti-tumor and anti-infective immune responses similar to those seen after bone marrow or stem cell transplantation but without the need for matched donors or associated side effects. Their lead product candidates include AlloStim®, a bioengineered living cell therapy, and CRCL, a patient-specific cancer vaccine. The company has conducted clinical trials in various cancers but some programs have been discontinued or are pending further development.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Living cell allografts (e.g., AlloStim)Patient-specific heat shock protein vaccines (CRCL)T cell vaccinesCancer vaccines
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Mirror Biologics Inc./Ltd.: Immunovative acts as licensor/exclusive consultant supporting Mirror’s commercialization efforts for AlloStim®.
Beyond the preview
Go deeper on Immunovative Therapies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Immunovative Therapies.